Correction: Preclinical In Vivo Data Integrated in a Modeling Network Informs a Refined Clinical Strategy for a CD3 T‑Cell Bispecific in Combination with Anti‑PD‑L1

被引：0
|
作者：
Javier Sánchez
Valeria Nicolini
Linda Fahrni
Inja Waldhauer
Antje‑Christine Walz
Candice Jamois
Stephen Fowler
Silke Simon
Christian Klein
Pablo Umaña
Lena E. Friberg
Nicolas Frances
机构：
[1] Roche Innovation Center Basel,Roche Pharma Research and Early Development
[2] F. Hoffmann-La Roche Ltd.,Department of Pharmacy
[3] Uppsala University,Roche Pharma Research and Early Development
[4] Roche Innovation Center Zurich,undefined
来源：
The AAPS Journal | / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 22 条
  • [21] MHC class I upregulation contributes to the therapeutic response to radiotherapy in combination with anti-PD-L1/anti-TGF-(3 in squamous cell carcinomas with enhanced CD8 T cell memory-driven response
    Lind, Hanne T.
    Hall, Spencer C.
    Strait, Alexander A.
    Goon, Jack B.
    Aleman, John D.
    Chen, Samantha M. Y.
    Karam, Sana D.
    Young, Christian D.
    Wang, Jing H.
    Wang, Xiao-Jing
    CANCER LETTERS, 2025, 608
  • [22] Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques
    Chen, Ping
    Chen, Hui
    Moussa, Maha
    Cheng, Jie
    Li, Tong
    Qin, Jing
    Lifson, Jeffrey D.
    Sneller, Michael C.
    Krymskaya, Ludmila
    Godin, Steven
    Lane, H. Clifford
    Catalfamo, Marta
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (04): : 523 - 533
123